A7910
Apolipoprotein C-II from human plasma
≥95% (SDS-PAGE)
Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Cambiar Vistas
| Talla/SKU | Disponibilidad | Precio |
|---|---|---|
50 μg | Póngase en contacto con nuestro Servicio de Atención al Cliente para disponibilidad | 256,00 € |
Acerca de este artículo
256,00 €
Póngase en contacto con nuestro Servicio de Atención al Cliente para disponibilidad
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarlebiological source
human
Quality Segment
assay
≥95% (SDS-PAGE)
form
powder
mol wt
average mol wt 8.8 kDa
technique(s)
ligand binding assay: suitable
UniProt accession no.
storage temp.
−20°C
Gene Information
human ... APOC2(344)
General description
Apolipoprotein C-II (APOC2/apoC-II), a small exchangeable apolipoprotein, is expressed in the liver and secreted into plasma. It is present on the triglyceride-rich lipoproteins (TRL), like chylomicrons (CM) and very-low-density lipoproteins (VLDL), and high-density lipoproteins (HDL), mainly during fasting. The intestine, macrophages, adipose tissue, brain, skin, lungs, retina, and retinal pigment epithelium are among the tissues that produce ApoC-II.
Application
Apolipoprotein C-II activates lipoprotein lipase and has been used in a study to assess HDL proteome in hemodialysis patients. An excess of apolipoprotein C-II is associated with increased triglyceride-rich particles and alterations in HDL particle distribution.
Biochem/physiol Actions
Apolipoprotein C2 (APOC2) serves as an activator of lipoprotein lipase. It is involved in the hydrolysis of triglycerides (TG) on TG-rich lipoproteins (TRL) to release free fatty acids (FA). Higher expression of APOC2 is observed in patient-derived glioblastoma stem cells, hypopharyngeal cancer, invasive ductal breast cancer, clear cell renal cell carcinoma, gastric cancer, centroblastic lymphoma, early-stage colorectal tumor, and skin squamous cell carcinoma. ApoC-2 is considered as a new sensitive biomarker for diagnosing Takayasu arteritis (TAK).
Activates lipoprotein lipase
1 of 1
Este artículo | |||
|---|---|---|---|
| description ≥95% (SDS-PAGE) | description - | description buffered aqueous solution | description Native apolipoprotein A-II from human plasma. The second most abundant protein of HDL. Binds to phospholipids during lipoprotein metabolism. Displaces LCAT bound to lipoprotein. |
| assay ≥95% (SDS-PAGE) | assay - | assay ≥95% (SDS-GE) | assay ≥95% (SDS-PAGE) |
| biological source human | biological source - | biological source human plasma | biological source - |
| technique(s) ligand binding assay: suitable | technique(s) ELISA: suitable | technique(s) electrophoresis: suitable | technique(s) - |
| storage temp. −20°C | storage temp. −20°C | storage temp. −20°C | storage temp. −20°C |
| form powder | form - | form buffered aqueous solution | form liquid |
| Quality Level 200 | Quality Level - | Quality Level 200 | Quality Level 100 |
Clase de almacenamiento
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.